Safety of micafungin in infants: insights into optimal dosing

Author： Ascher Simon Smith Phillip Brian Benjamin Daniel K

ISSN： 1474-0338

Source： Expert Opinion on Drug Safety, Vol.10, Iss.2, 2011-03, pp. : 281-286

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Micafungin

By Jarvis B. Figgitt D.P. Scott L.J.

Drugs, Vol. 64, Iss. 9, 2004-01 ,pp. : 969-982

Adis International

Access to resources Recommend Favorite

Accumulated safety data of micafungin in therapy and prophylaxis in fungal diseases

By Cornely Oliver A Pappas Peter G Young Jo-Anne H Maddison Philip Ullmann Andrew J

Expert Opinion on Drug Safety, Vol. 10, Iss. 2, 2011-03 ,pp. : 171-183

Informa Healthcare

Access to resources Recommend Favorite

Fluconazole Pharmacokinetics and Safety in Premature Infants

Current Medicinal Chemistry, Vol. 19, Iss. 27, 2012-09 ,pp. : 4617-4620

Bentham Science Publishers

Access to resources Recommend Favorite

Optimal Frequency of Lithium Administration in the Treatment of Bipolar Disorder: Clinical and Dosing Considerations

By Malhi Gin S. Tanious Michelle

CNS Drugs, Vol. 25, Iss. 4, 2011-04 ,pp. : 289-298

Adis International

Access to resources Recommend Favorite

RIX 4414 shows safety and immunogenicity in infants

Inpharma, Vol. 1, Iss. 1664, 2008-01 ,pp. : 20-20

Adis International

Access to resources Recommend Favorite